GG
Gleason Group Portfolio holdings
AUM
$923M
1-Year Return
13.47%
This Quarter Return
-3.47%
1 Year Return
+13.47%
3 Year Return
+56.47%
5 Year Return
+87.83%
10 Year Return
–
AUM
$381M
AUM Growth
-$4.77M
(-1.2%)
Cap. Flow
+$9.07M
Cap. Flow
% of AUM
2.38%
Top 10 Holdings %
Top 10 Hldgs %
81.09%
Holding
238
New
6
Increased
124
Reduced
32
Closed
3
Top Buys
| 1 |
Vanguard Total Stock Market ETF
VTI
|
$3.06M |
| 2 |
Vanguard S&P 500 ETF
VOO
|
$1.92M |
| 3 |
Schwab US Large- Cap ETF
SCHX
|
$1.9M |
| 4 |
Vanguard Total International Stock ETF
VXUS
|
$1.57M |
| 5 |
Vanguard Extended Market ETF
VXF
|
$1.05M |
Top Sells
| 1 |
Vanguard Dividend Appreciation ETF
VIG
|
$1.01M |
| 2 |
Vanguard High Dividend Yield ETF
VYM
|
$987K |
| 3 |
Vanguard Growth ETF
VUG
|
$167K |
| 4 |
Intel
INTC
|
$112K |
| 5 |
Exxon Mobil
XOM
|
$82.2K |
Sector Composition
| 1 | Consumer Staples | 1.99% |
| 2 | Financials | 1.72% |
| 3 | Industrials | 1.62% |
| 4 | Technology | 1.25% |
| 5 | Consumer Discretionary | 1.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
151
Allstate
ALL
$54.9B
| $19.9K | 0.01% |
179
+2
| +1% | +$222 |
|
152
MiMedx Group
MDXG
$1.05B
| $19.8K | 0.01% |
2,712
| – | – |
|
153
DuPont de Nemours
DD
$32.3B
| $19.4K | 0.01% |
260
-80
| -24% | -$5.97K |
|
154
Orion Group Holdings
ORN
$304M
| $18.1K | ﹤0.01% |
3,382
| – | – |
|
155
Diageo
DEO
$61.1B
| $17.5K | ﹤0.01% |
118
| – | – |
|
156
Invesco S&P 500 Pure Value ETF
RPV
$1.35B
| $17.2K | ﹤0.01% |
234
+2
| +0.9% | +$147 |
|
157
AbbVie
ABBV
$376B
| $17.1K | ﹤0.01% |
115
+1
| +0.9% | +$149 |
|
158
Invesco S&P 500 Pure Growth ETF
RPG
$1.73B
| $17.1K | ﹤0.01% |
566
+1
| +0.2% | +$30 |
|
159
Comcast
CMCSA
$125B
| $17K | ﹤0.01% |
383
+3
| +0.8% | +$133 |
|
160
US Bancorp
USB
$76.5B
| $16K | ﹤0.01% |
484
+7
| +1% | +$231 |
|
161
Technology Select Sector SPDR Fund
XLK
$84B
| $15.8K | ﹤0.01% |
96
| – | – |
|
162
iShares MSCI EAFE ETF
EFA
$65.9B
| $15.6K | ﹤0.01% |
226
| – | – |
|
163
Eversource Energy
ES
$23.5B
| $15.6K | ﹤0.01% |
268
+3
| +1% | +$174 |
|
164
iShares Morningstar Mid-Cap Value ETF
IMCV
$828M
| $15.3K | ﹤0.01% |
253
| – | – |
|
165
Rivian
RIVN
$16.6B
| $14.6K | ﹤0.01% |
600
| – | – |
|
166
Philip Morris
PM
$251B
| $14.2K | ﹤0.01% |
154
+2
| +1% | +$185 |
|
167
Marsh & McLennan
MMC
$101B
| $14.2K | ﹤0.01% |
75
+1
| +1% | +$189 |
|
168
Cue Biopharma
CUE
$60.3M
| $13.8K | ﹤0.01% |
6,000
| – | – |
|
169
Elevance Health
ELV
$69.4B
| $13.3K | ﹤0.01% |
31
+1
| +3% | +$429 |
|
170
Corteva
CTVA
$49.3B
| $13K | ﹤0.01% |
254
-79
| -24% | -$4.04K |
|
171
Polaris
PII
$3.26B
| $12.6K | ﹤0.01% |
121
+1
| +0.8% | +$104 |
|
172
NVIDIA
NVDA
$4.18T
| $12.2K | ﹤0.01% |
280
| – | – |
|
173
Vanguard FTSE Developed Markets ETF
VEA
$170B
| $12.2K | ﹤0.01% |
279
+2
| +0.7% | +$87 |
|
174
Vanguard Information Technology ETF
VGT
$99.7B
| $12.1K | ﹤0.01% |
29
| – | – |
|
175
United Bankshares
UBSI
$5.47B
| $11.4K | ﹤0.01% |
413
+5
| +1% | +$138 |
|